Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Cytokine Effects on the Entry of Filovirus Envelope Pseudotyped Virus-Like Particles into Primary Human Macrophages.

Stantchev TS, Zack-Taylor A, Mattson N, Strebel K, Broder CC, Clouse KA.

Viruses. 2019 Sep 23;11(10). pii: E889. doi: 10.3390/v11100889.

2.

Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infection.

Stantchev TS, Paciga M, Lankford CR, Schwartzkopff F, Broder CC, Clouse KA.

Retrovirology. 2012 Dec 3;9:97. doi: 10.1186/1742-4690-9-97.

3.
4.

Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry.

Dube D, Schornberg KL, Shoemaker CJ, Delos SE, Stantchev TS, Clouse KA, Broder CC, White JM.

Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16637-42. doi: 10.1073/pnas.1008509107. Epub 2010 Sep 3.

5.

Expression of Human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection.

Blanco JC, Pletneva LM, Wieczorek L, Khetawat D, Stantchev TS, Broder CC, Polonis VR, Prince GA.

Virol J. 2009 May 14;6:57. doi: 10.1186/1743-422X-6-57.

6.

Cell adhesion promotes Ebola virus envelope glycoprotein-mediated binding and infection.

Dube D, Schornberg KL, Stantchev TS, Bonaparte MI, Delos SE, Bouton AH, Broder CC, White JM.

J Virol. 2008 Jul;82(14):7238-42. doi: 10.1128/JVI.00425-08. Epub 2008 Apr 30.

7.

Identification of Hendra virus G glycoprotein residues that are critical for receptor binding.

Bishop KA, Stantchev TS, Hickey AC, Khetawat D, Bossart KN, Krasnoperov V, Gill P, Feng YR, Wang L, Eaton BT, Wang LF, Broder CC.

J Virol. 2007 Jun;81(11):5893-901. Epub 2007 Mar 21.

8.

The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages.

Stantchev TS, Markovic I, Telford WG, Clouse KA, Broder CC.

Virus Res. 2007 Feb;123(2):178-89. Epub 2006 Oct 9.

9.

Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry.

Markovic I, Stantchev TS, Fields KH, Tiffany LJ, TomiƧ M, Weiss CD, Broder CC, Strebel K, Clouse KA.

Blood. 2004 Mar 1;103(5):1586-94. Epub 2003 Oct 30.

PMID:
14592831
10.

Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors.

Stantchev TS, Broder CC.

Cytokine Growth Factor Rev. 2001 Jun-Sep;12(2-3):219-43. Review. Erratum in: Cytokine Growth Factor Rev 2001 Dec;12(4):395-8.

PMID:
11325604
12.

Inefficient formation of a complex among CXCR4, CD4 and gp120 in U937 clones resistant to X4 gp120-gp41-mediated fusion.

Xiao X, Norwood D, Feng YR, Moriuchi M, Jones-Trower A, Stantchev TS, Moriuchi H, Broder CC, Dimitrov DS.

Exp Mol Pathol. 2000 Jun;68(3):139-46.

PMID:
10816382
13.

Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.

Lee S, Lapham CK, Chen H, King L, Manischewitz J, Romantseva T, Mostowski H, Stantchev TS, Broder CC, Golding H.

J Virol. 2000 Jun;74(11):5016-23.

14.

Constitutive cell surface association between CD4 and CCR5.

Xiao X, Wu L, Stantchev TS, Feng YR, Ugolini S, Chen H, Shen Z, Riley JL, Broder CC, Sattentau QJ, Dimitrov DS.

Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7496-501.

15.

A mechanism of resistance to HIV-1 entry: inefficient interactions of CXCR4 with CD4 and gp120 in macrophages.

Dimitrov DS, Norwood D, Stantchev TS, Feng Y, Xiao X, Broder CC.

Virology. 1999 Jun 20;259(1):1-6.

Supplemental Content

Loading ...
Support Center